Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
Department of Health and Human Services
The goal of the NHLBI Catalyze Program is to provide a comprehensive suite of support and services to facilitate the transition of basic science discoveries into viable diagnostic and therapeutic candidates that have been cleared for human testing, and to develop translational researchers fluent in product development and entrepreneurship. This specific Catalyze Product Definition initiative will provide the early stage translational support needed for the activities required to identify and characterize potential therapeutic candidates and combination products to treat HLBS diseases and disorders. This initiative has a companion initiative that supports development of devices and diagnostic
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Later
Posted
11/22/2024
Closes
2027-12-23
Eligibility
Eligibility
Private institutions of higher educationIndependent school districtsPublic and State controlled institutions of higher educationSmall businessesState governmentsNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationNative American tribal governments (Federally recognized)County governmentsOthers (see text field entitled "Additional Information on Eligibility" for clarification)City or township governmentsSpecial district governmentsNative American tribal organizations (other than Federally recognized tribal governments)For profit organizations other than small businessesPublic housing authorities/Indian housing authorities
Program
Funding area
Health - HL
Opportunity #
RFA-HL-26-018
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov